Navigation Links
SyntheMed Receives Russian Regulatory Approval for REPEL-CV(TM)
Date:8/18/2009

ISELIN, N.J., Aug. 18 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Ministry of Health of the Russian Federation for use in all patients who undergo open heart surgery. REPEL-CV will be marketed throughout Russia by Cardiomedics, Ltd., a distributor of cardiac surgery products. Marc Sportsman, SyntheMed's Vice President of Sales, stated, "We are pleased that this regulatory and clinical evaluation process has been successfully completed and we can proceed with the launch of REPEL-CV in this important market."

REPEL-CV is FDA approved for use in pediatric cardiac surgery patients and is marketed in the United States through a direct sales force. It also has CE Mark approval for use in all cardiac surgery patients and is marketed in the European Union and certain other international countries through a network of independent distributors.

About Adhesions

Adhesions, or scar tissue, occur after virtually all open-heart surgical procedures, often resulting in the heart becoming attached to the sternum and other surrounding tissue surfaces. The presence of adhesions represents a prevalent and serious complication in secondary surgical procedures, increasing the length, cost and risk of the surgical procedure.

About REPEL-CV

REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over the surface of the heart at the conclusion of an open-heart surgical procedure to reduce the extent and severity of adhesions (scar tissue) that form between the surface of the heart and opposing tissue surfaces following the surgical procedure. It is designed to perform the ther
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SyntheMed Receives US Patent on Novel Polymer Technology
2. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
3. SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
4. FDA Approves SyntheMeds REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
5. SyntheMed Announces FDA Clearance of SinusShield(TM)
6. SyntheMed Announces New Management Appointments
7. SyntheMed Completes $4.0 Million Equity Placement
8. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
9. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
10. SyntheMed Files Universal Shelf Registration
11. SyntheMed to Present at the Acumen BioFin Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
(Date:12/24/2014)... and NEW YORK , Dec. ... biopharmaceutical company advancing patient care in critical areas, announced the ... common stock, and warrants to purchase up to an aggregate ... $4.00 per share and $.01 per warrant.  The warrants have ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... MA (PRWEB) December 23, 2014 ... is designed to introduce cutting edge communication technology, ... of platform upgrades. This webinar series demonstrates online ... quest to leverage web conferencing’s most innovative and ...
Breaking Biology Technology:Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3
... Inc.,( http://www.nikoninstruments.com/ ) announced its new SMZ-445/460,stereoscopic zoom ... at a low cost for the Industrial and ... range of applications, from routine,quality control to semiconductor ... to 3.5x zoom magnification, and SMZ-460, 0.7x to,3.0x ...
... SAFE-BioPharma Association First to Offer TriCipher ID Tool ToGo ... Pharmaceutical and ... TriCipher, the strong,authentication company, has created the first SAFE-BioPharma(TM) ... Key Infrastructure,Policy Authority (FPKIPA), the interagency body that enforces ...
... 15, Agendia BV and Ferrer inCode today announced ... sell two of Agendia,s,signature cancer diagnostic services -- ... to indicate risk of breast cancer tumor,recurrence, and ... fast and reliable method of identifying the primary ...
Cached Biology Technology:Nikon Instruments Introduces New Microscopes and Illumination Stand for Education and OEM Markets 2TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 2TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 3TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 4Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets 2Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets 3
(Date:12/19/2014)... 18, 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) ... North America Perimeter Security Systems Market" report to their ... The North American perimeter security market is estimated to grow ... the U.S. market holds a larger share in this market, ...
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ...
(Date:12/17/2014)... 2014 The Defense Logistics Agency is insourcing its ... counterfeit microcircuits from entering into its supply chain. ... anti-counterfeit initiative dubbed DNA marking. The capability will validate ... throughout the supply chain. The new quality control measures ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... award of the Graduate School of Excellence "Materials Science ... and Christine Tonhauser. Anna Maria Hofmann received the prize ... Tonhauser was honored for her thesis on functional polyethylene ... science includes prize money of EUR 2,000 and has ...
... A Ben-Gurion University of the Negev (BGU) study indicates that ... (PTSD) if their mother is already afflicted. In the ... , while fewer than 10 percent (8.4 percent) of the ... percent) of their children presented PTSD symptoms. Children who developed ...
... as the leader in biomedical research and within the next ... it spends for R&D, according to Francis Collins, M.D., Ph.D, ... at a Festival of Science at the University of Maryland ... With Congress unable to settle on a budget for the ...
Cached Biology News:MAINZ award for Anna Maria Hofmann and Christine Tonhauser 2NIH director warns that US research funding is falling behind, calls for new focus on innovation 2NIH director warns that US research funding is falling behind, calls for new focus on innovation 3
... basic power supply are used for submerged horizontal ... This Model 96 cell includes a buffer tank, ... with fluorescent ruler, and a gel caster. The ... provides output of 10-300 V, 4-400 mA, and ...
... The Sub-Cell Model 192 and PowerPac basic power ... of nucleic acids in agarose gels. This Model ... x 15 cm UV-transparent gel tray with fluorescent ... power supply, 100-120 and 220-240 V, provides output ...
... The Sequi-Gen GT and PowerPac 3000 system, 220-240 ... a 38 x 30 cm vertical slab gel ... electrophoresis cell, which is capable of separating nucleic ... integral plate chamber (IPC) assembly (IPC and bonded ...
The imaging screen-K (Kodak), is a 35 x 43 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
Biology Products: